Gamma Knife – Targeted Brain Tumor Treatment
Gamma Knife Market which has been introduced decades ago, is one of the most effective non-invasive technologies that is steadily gaining traction in the treatment of tumors. Gamma knife surgery represents a major advancement in brain surgery, with a one-day treatment procedure. Patients can go home the same day after treatment with gamma knife.Leksell Gamma Knife is the among most efficient gamma knife devices in the market. The device radiates 201 beams that converge at the lesion point, thus destroying only the affected or target tissue. The device can be programmed to for multiple sessions.
Increasing awareness about the high affectivity of these products and their lowering cost will increase the adoption of this device in the near future. Increase in healthcare investments in China, India, Brazil, and other emerging economies would be a major contributing factor towards increase in revenues of the global gamma knife market.This report segments the global gamma knife market on the basis of indication, anatomy and geography. On the basis of indication, the global gamma knife market is segmented into brain metastasis, trigeminal neuralgia, Arteriovenous Malformation (AVM), cancer, movement disorders and others.
Request a Sample Copy of the Business Report:https://www.coherentmarketinsights.com/insight/request-sample/408
Key features of the study:
This report provides in-depth analysis of the gamma knife and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR (%)) for the forecast period: 2017 – 2025, considering 2016 as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches, approvals, regional outlook, and competitive strategies adopted by the leading players
It profiles leading players in the global gamma knife market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies and future plans
Global Gamma Knife Market, By Indication:
Brain Metastasis,Arteriovenous Malformation (AVM),Cancer,Trigeminal Neuralgia,Movement Disorders,Others,.
Global Gamma Knife Market, By Anatomy:
Ask for customization: https://www.coherentmarketinsights.com/insight/request-customization/408
Gamma knife radiotherapy involves convergence of 201 beams that can treat the tumor cell leaving precisely leaving the surrounding healthy cells undamaged. Utilizing the pre-operative diagnostic images form CT/MRI scan, the instrument provides highly accurate irradiation at the tumor site. This is a major factor that drives the usage of gamma knife radiotherapy in treating brain tumors. Application of this procedure is increasing further in trigeminal neuralgia, and arteriovenous malformations. However, gamma knife is limited to 190 positions to reach the tumor cells.
The U.S. federal government reduced Medicare reimbursement for gamma knife treatment from US $8,100 to US $3,400 in 2013. This further reduces the accessibility of a highly precise brain tumor treatment method to the general population in the U.S. Although an alternative technology, Cyber Knife, is available, many physician prefer using gamma knife over linac-based surgery based on their comfort and skills. Therefore, the gamma knife market is expected to experience a gradual growth.
You may be interested
Anti-Suicide Drugs Market Boosting the Growth By Top Players Pfizer, Inc., AstraZeneca plc, Eli Lilly and Company, Allergan plc, GlaxoSmithKline plc, Merck & Co., Inc., H. Lundbeck A/S, NeuroRx, Inc., and Johnson & Johnson.Albert R - November 16, 2018
“Anti-Suicide Drugs Market is expected to have a highly positive outlook for the next five years 2018–2026 according to a recently released Anti-Suicide Drugs Market research report.…
New Study Reports Odds of Living to 110-Plus Level out After the Age of 105Mohit Joshi - November 16, 2018
Researchers from University of California – Berkeley report that chances of reaching the age of 110 are increased once a person survives for 105 years. A research…
Researchers Discover New Toxic Gene in Cholera BacteriaMohit Joshi - November 15, 2018
Researchers from Umea University discovered structure and function of an unknown Vibrio toxin in Cholera bacteria The bacterium Vibrio cholera is the main cause of bacterial infectious…